Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

KalVista Pharmaceuticals (KALV) Times Interest Earned (2025)

KalVista Pharmaceuticals' Times Interest Earned history spans 3 years, with the latest figure at -$74.18 for Q1 2016.

  • On a quarterly basis, Times Interest Earned fell 1165.37% to -$74.18 in Q1 2016 year-over-year; TTM through Jan 2017 was -$270.34, a N/A change, with the full-year FY2025 number at -$32.5, changed N/A from a year prior.
  • Times Interest Earned hit -$74.18 in Q1 2016 for KalVista Pharmaceuticals, down from -$63.28 in the prior quarter.
  • Over the last five years, Times Interest Earned for KALV hit a ceiling of -$5.86 in Q1 2015 and a floor of -$74.18 in Q1 2016.
  • Historically, Times Interest Earned has averaged -$36.37 across 3 years, with a median of -$31.44 in 2014.
  • Biggest five-year swings in Times Interest Earned: skyrocketed 74.73% in 2015 and later crashed 1165.37% in 2016.
  • Tracing KALV's Times Interest Earned over 3 years: stood at -$9.99 in 2014, then plummeted by 533.2% to -$63.28 in 2015, then fell by 17.22% to -$74.18 in 2016.
  • Business Quant data shows Times Interest Earned for KALV at -$74.18 in Q1 2016, -$63.28 in Q4 2015, and -$51.57 in Q3 2015.